[An update on the pharmacological treatment of attention deficit hyperactivity disorder: lisdexamphetamine and extended-release guanfacine]. [electronic resource]
- Revista de neurologia Mar 2017
- S1-S8 p. digital
Publication Type: Journal Article; Review
1576-6578
Adrenergic alpha-2 Receptor Agonists--therapeutic use Attention Deficit Disorder with Hyperactivity--drug therapy Central Nervous System Stimulants--therapeutic use Delayed-Action Preparations Guanfacine--therapeutic use Humans Lisdexamfetamine Dimesylate--therapeutic use